Mewis C, Kühlkamp V, Dörnberger V, Mermi J, Seipel L
Medizinische Klinik III der Universitätsklinik Tübingen.
Z Kardiol. 1997 Feb;86(2):85-94. doi: 10.1007/s003920050038.
With the growing complexity of transvenous ICD-lead systems the incidence of lead complications might increase in comparison to usual pacemaker leads. The incidence of insulation defects of transvenous leads was determined during a mean follow-up time of 23.8 +/- 10.9 months. Among 130 transvenous ICD-patients, eight insulation-breaks in seven patients (6%) could be identified after a mean follow-up of 28 +/- 13 months. After a follow-up period of 12 months no lead defect was identified, after 24 months 96.3 +/- 1.8% of all transvenous leads were free of complications, after 36 months 87.9 +/- 6% and after 48 months in 61.2 +/- 18.7% of all leads no isolator fracture was found. In seven cases an operative revision was required. All insulation-defects were exclusively found in abdominally implanted silicone lead-systems type Endotak/CPI (Cardiac Pacemakers, Inc., USA): isolator fractures occurred in 12% of all Endotak leads used, 19% of the Endotak C models 62, 64, 72 and 74 were affected. In none of 66 implanted Transvene lead systems (Medtronic, Inc., USA) were isolator defects found. In six patients the proximal part of the sensing lead near the device was affected. All of these patients experienced potentially harmful repetitive device discharges. In one patient during elective ICD-replacement an isolation break of the proximal shock electrode was found, in another patient between the proximal and distal shock-electrode. Despite regular follow-ups with impedance-measurements, only in one case was the insulation break foreseeable. Stored electrograms were helpful to disclose insulation defects. With increasing age of the transvenous lead systems a growing number of insulation defects has to be expected. Especially the isolators of the first Endotak C models 60-74 seem to create major problems with increasing age.
随着经静脉植入式心律转复除颤器(ICD)导线系统日益复杂,与普通起搏器导线相比,导线并发症的发生率可能会增加。在平均随访时间为23.8±10.9个月期间,确定了经静脉导线绝缘缺陷的发生率。在130例经静脉植入ICD的患者中,平均随访28±13个月后,7例患者(6%)出现了8处绝缘破损。随访12个月后未发现导线缺陷,24个月后96.3±1.8%的经静脉导线无并发症,36个月后为87.9±6%,48个月后61.2±18.7%的导线未发现隔离器断裂。7例患者需要进行手术修复。所有绝缘缺陷均仅在腹部植入的Endotak/CPI型硅橡胶导线系统(美国心脏起搏器公司)中发现:所有使用的Endotak导线中有12%发生了隔离器断裂,Endotak C型号62、64、72和74中有19%受到影响。在66例植入的Transvene导线系统(美国美敦力公司)中均未发现隔离器缺陷。6例患者靠近设备的感知导线近端部分受到影响。所有这些患者都经历了可能有害的设备反复放电。1例患者在择期更换ICD时发现近端电击电极隔离中断,另1例患者在近端和远端电击电极之间出现隔离中断。尽管定期进行阻抗测量随访,但只有1例绝缘破损是可预见的。存储的心电图有助于发现绝缘缺陷。随着经静脉导线系统使用年限的增加,预计绝缘缺陷的数量会越来越多。特别是第一代Endotak C型号60 - 74的隔离器随着使用年限的增加似乎会产生重大问题。